A Study of AK157D1 for Injection in Advanced Solid Tumors

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This is an first-in-human, Phase I clinical study aimed at evaluating the safety, tolerability, PK, immunogenicity, and preliminary antitumor efficacy of AK157D1 for injection in advanced solid tumors.
Epistemonikos ID: e3b0c603cf7fb0d4c79954cacc8291bcd6f364f6
First added on: Sep 30, 2026